Merck halts shipments of key cancer drug to Greece

The German pharmaceuticals maker Merck will no longer deliver the cancer drug Erbitux to Greek hospitals, according to a statement from the company today. The drug also known as cetuximab is often used for patients with head and neck cancers. The move to halt distribution is a sign of a worsening economic and budget crisis, and its impact on critical services including care for cancer patients. (thanks, Gerrit)
Loading...